Clinical trials
Completed Phase 1 Leukemia, Megakaryoblastic, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 8 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 13 |
| Case Comprehensive Cancer Center | 4 |
| Roswell Park Cancer Institute | 3 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| M.D. Anderson Cancer Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Nohla Therapeutics, Inc. | 1 |
| Paolo Caimi, MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Erythroblastic, Acute | 35 |
| Leukemia, Megakaryoblastic, Acute | 35 |
| Leukemia, Myeloid, Acute | 35 |
| Leukemia, Monocytic, Acute | 34 |
| Leukemia, Myelomonocytic, Acute | 33 |
| Congenital Abnormalities | 25 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 20 |
| Leukemia | 17 |
| Blast Crisis | 16 |
| Leukemia, Basophilic, Acute | 16 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.